Arizona State Retirement System Clovis Oncology, Inc. Transaction History

Arizona State Retirement System

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 28, 2022	SELL	$0.63 - $2.96 $21,028 - $98,801	-33,379 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$1.43 - $3.14 $4,437 - $9,743	3,103 Added 10.25%	33,379 $67,000
Q4 2021 Feb 04, 2022	BUY	$2.7 - $4.76 $8,685 - $15,312	3,217 Added 11.89%	30,276 $82,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $267 - $382	66 Added 0.24%	27,059 $121,000
Q2 2021 Aug 02, 2021	BUY	$5.02 - $7.05 $12,896 - $18,111	2,569 Added 10.52%	26,993 $157,000
Q1 2021 May 06, 2021	BUY	$4.81 - $10.34 $740 - $1,592	154 Added 0.63%	24,424 $171,000
Q4 2020 Jan 28, 2021	SELL	$4.13 - $6.41 $3,931 - $6,102	-952 Reduced 3.77%	24,270 $116,000
Q3 2020 Nov 05, 2020	BUY	$4.82 - $7.72 $30,631 - $49,060	6,355 Added 33.68%	25,222 $147,000
Q2 2020 Aug 04, 2020	BUY	$5.69 - $9.69 $107,353 - $182,821	18,867 New	18,867 $127,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

Stay updated on Arizona State Retirement System with notifications on news.